Skip to main navigation Skip to search Skip to main content

Development and validation of a UPLC-MS/MS method for the simultaneous determination of paritaprevir and ritonavir in rat liver

  • SUNY Buffalo

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Aim: Determination of paritaprevir and ritonavir in rat liver tissue samples. Results: We successfully validated a UPLC-MS/MS method to measure paritaprevir and ritonavir in rat liver using deuterated internal standards (d8-paritapervir and d6-ritonavir). The method is linear from 20 to 20,000 and 5 to 10,000 pg on column for paritaprevir and ritonavir, respectively, and is normalized per milligram tissue. Interday and intraday variability ranged from 0.591 to 5.33% and accuracy ranged from -6.68 to 10.1% for quality control samples. The method was then applied to the measurement of paritaprevir and ritonavir in rat liver tissue samples from a pilot study. Conclusion: The validated method is suitable for measurement of paritaprevir and ritonavir within rat liver tissue samples for PK studies.

Original languageEnglish
Pages (from-to)1353-1363
Number of pages11
JournalBioanalysis
Volume8
Issue number13
DOIs
StatePublished - Jul 2016

Keywords

  • UPLC-MS/MS
  • core needle biopsy
  • fine needle aspirate
  • liver
  • paritaprevir
  • ritonavir
  • validation

Fingerprint

Dive into the research topics of 'Development and validation of a UPLC-MS/MS method for the simultaneous determination of paritaprevir and ritonavir in rat liver'. Together they form a unique fingerprint.

Cite this